Table 1 Diagnostic characteristics from the initial 21 surgical cases with intraoperative MS analysis.

From: Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery

 

Invasive carcinoma type

Tumor size (cm)

Overall histological grade

DCIS/LCIS present?

AJCC stage

ER

PR

Her-2

1

Mixed

1.6

Poor

DCIS

T1c N0 (sn)

+

+

2

Mixed

1.5

Moderate

LCIS

pT1c N0 (sn)

+

+

3

Mixed

1.1 0.25

Moderate

LCIS

pT1c N0 (sn)

+

+

4

Ductal

1.4

Well

Mixed

T1c N1a

+

+

+/−

5

Ductal

1

Moderate

 

pT1b N0 (sn)

+

+

6

Ductal

1.6

Well

DCIS

T1c N0 (sn)

+

+

7

Ductal

1.7

Poor

DCIS

pT1c N0 (sn)

8

Ductal

2.1

Poor

 

pT2 N0(sn)

9

Ductal

0.8

0.5

Well

DCIS

pm T1b N0 (sn)

+

+

10

Ductal

0.9

Well

DCIS

T1b N0(sn)

+

+

11

Ductal

0.6

Moderate

DCIS

pT1b Nx

+

+

12

Ductal with spindle features

0.6

Moderate

DCIS

pT1b N1a (sn)

13

Ductal

1.9

Poor

DCIS

pT1c N0 (sn)

+

+

14

Ductal

1.9

Moderate

 

pT1c N0 (sn)

+

+

15

Mixed

0.7

Well

 

pT1b N0

+

+

16

Lobular

0.4; <0.1

Moderate

LCIS

pT1b N0 (sn)

+

+

17

Tubular

0.8

Well

 

pT1bN0

+

+

18

Lobular

0.9

Well

 

pT1b N0(sn)

+

+

19

Ductal; Mixed

1.3; 0.9

Moderate; Well

DCIS

pT1c N1mi (two loci)

+

+

20

Micropapillary mucinous

2.4

Moderate

DCIS

pT2 N0 (sn)

+

+

21

Mixed

1.5

Moderate

DCIS

pT1c N0

+

+

  1. DCIS ductal carcinoma in situ, LCIS lobular carcinoma in situ, LVI lymphovascular invasion, ER estrogen receptor, PR progesterone receptor, Nx No lymph nodes available for evaluation.
  2. *SRS analyzed.